CD274 and non-small cell lung carcinoma: To validate these findings in NSCLC patients with a high prevalence of EGFR mutations, we retrospectively analyzed the assay concordance of PD-L1 IHC staining in NSCLC patients and attempted to determine the possible predictors of high PD-L1 expression.